Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party. Lung Cancer. 2012 Sep; 77(3):605-10.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Cisplatin
Costs and Cost Analysis
Deoxycytidine
Female
Humans
Ifosfamide
Kaplan-Meier Estimate
Lung Neoplasms
Male
Middle Aged
Mitomycin
Multivariate Analysis
Neoadjuvant Therapy
Proportional Hazards Models
Treatment Outcome
Vinblastine

authors with profiles

David N. Lewin